Press Coverage
Sofinnova Capital
Henrijette Richter discusses R&D in plenary at WuXi Global Forum
Related Deal lead
Henrijette RichterRelated Strategy
CapitalHenrijette Richter, managing partner at Sofinnova Partners, participated in the opening plenary panel discussion at the WuXi Global Forum 2022 on January 10. Marking the 10th anniversary of the event, the panel, led by Jorge Conde, general partner at Andreessen Horowitz, took a look back at 10 years of breakthroughs that are changing the game in R&D productivity before turning their focus on the future. Henrijette joined David Berry, founder and CEO of Valo Health; Diego Miralles, CEO of Laronde, and Roger Perlmutter, chairman and CEO of Eikon Therapeutics.
View the replay here.
Related News
Elevara Medicines doses first patient in Phase 2b START-SYNERGY trial of ELV001 in rheumatoid arthritis patients with incomplete response to TNFi
May Health raises $11.7M to advance its novel technology to treat PCOS-related infertility
Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics
European Life Sciences Coalition launched to strengthen Europe’s life sciences investment ecosystem
The 15-20 National Hospital and GenSight Biologics announce the treatment of the first patient in the GS010/LUMEVOQ® REVISE Study